INTRODUCTION {#s1}
============

Breast cancer is the most prevalent cancer worldwide, with an estimated 4.4 million survivors within 5 years of diagnosis \[[@RJU063C1]\]. It is the second most common cancer-related cause of death among women, and the second most commonly diagnosed cancer (behind lung cancer) \[[@RJU063C1]\]. In the USA, the annual incidence of breast cancer is ∼82.5--99.4/100 000 women \[[@RJU063C1]\]. There are ∼180 000 cases diagnosed annually in the USA, with 41 000 deaths annually attributable to breast cancer \[[@RJU063C2]\]. Broadly speaking, invasive breast carcinoma may be classified into two groups, ductal and lobular types. There are different subtypes based upon specific morphological and immunohistochemical features. In ∼30--60% of cases, a mixed pattern is present. Clear cell carcinoma of the breast is a very rare neoplasm, with an estimated incidence between 1.4 and 3% of all cases of breast carcinomas \[[@RJU063C3], [@RJU063C4]\].

CASE REPORT {#s2}
===========

In our patient, the breast core biopsy showed multiple tiny foci of papillary proliferation with pseudo-lactational changes. However, the open biopsy showed poorly differentiated invasive ductal carcinoma with clear cell changes (Fig. [1](#RJU063F1){ref-type="fig"}). Ductal carcinoma *in situ* displays a papillary pattern with focal cystic hypersecretory (pseudo-lactating) features (Fig. [2](#RJU063F2){ref-type="fig"}). Microscopic examination showed that the tumor cells contained abundant fine glycogen granules in their clear cytoplasm, which were stained by a periodic acid-schiff (PAS) stain, but not stained by a diastase-PAS stain. There were features of poorly differentiated carcinoma with a prominent micropapillary growth pattern. Extensive ductal carcinoma *in situ* with solid, micropapillary, flat and cribriform types with an intermediate-to-high nuclear grade with necrosis was also noted. Invasive and *in situ* carcinomas both show clear cell and cystic hypersecretory changes. The breast core biopsy specimen showed atypical ductal hyperplasia with clear cell changes. Figure 1:Microscopic examination reveals tumor cells with ample clear cytoplasm, distinct cell borders and pleomorphic nuclear features (×20). Figure 2:Microscopic examination reveals well-formed angular and papillary epithelial tumor cells with ample clear cytoplasm (×20).

Clear cell carcinoma may be easily missed or under-diagnosed in a breast core biopsy specimen due to the fact that it tends to show a papillary pattern with clear cell and pseudo-lactating changes, especially in young female patients \[[@RJU063C5]\]. Normal breast tissue may possess clear cells as a consequence of the physiological changes of pregnancy, clearing of the cytoplasm within myoepithelial cells, or the clearing of the cytoplasm in apocrine metaplasia \[[@RJU063C5]\]. Clear cell changes may be found in pre- or post-menopausal women, and may indicate benign changes or carcinoma. In rare cases, clear cell changes and pseudo-lactating changes may both be present in the same breast sample, and may be histologically difficult to distinguish from one another.

Owing to the rarity of the subtype of carcinoma found in our patient, there is a wide discrepancy in the literature with regard to clinical presentation. After a review of case reports in the literature, patients are usually women in their late forties, presenting with a painless mass in their breast. Kuroda *et al.* report that among 20 cases of glycogen-rich clear cell carcinoma of the breast that they examined, the age at presentation ranged from 33 to 68 years (mean 52 years), size of tumor ranged from 1 to 6.5 cm (mean 2.6 cm) and 7/20 cases (35%) that underwent an axillary lymph node dissection had positive lymph nodes. Fifteen of these cases were followed for 6 years, and 5/15 (33%) died within 5 years of diagnosis \[[@RJU063C4]\]. There is no clear consensus regarding prognosis, but it clearly follows an aggressive clinical course with reports of local recurrence, multiple recurrences and distant metastases \[[@RJU063C3], [@RJU063C4], [@RJU063C6], [@RJU063C7]\].

DISCUSSION {#s3}
==========

Breast cancer with glycogen-rich clear cell changes was first described in a 49-year-old woman by Hull *et al.* in 1981 \[[@RJU063C4], [@RJU063C6]\]. Electron microscopy showed neoplastic cells with non-membrane-bound particulate glycogen, which formed many acini. These cells had microvilli apically, and tight junctions as well as desmosomes laterally. Hull *et al.* \[[@RJU063C6]\] concluded that the morphological features were similar to those of fetal breast, as well as to clear cell carcinomas of other organs. It is estimated that the incidence of glycogen-rich clear cell carcinoma of the breast nears 1.4--3% of all breast cancers. The criteria used for the diagnosis of this tumor subtype are that cells consist primarily of cytoplasm that is clear and occasionally granular, with PAS stain positivity and diastase-labile material in at least 90% of the area of the tumor \[[@RJU063C8]\].

According to Kim *et al.*, \[[@RJU063C9]\] as of 2012, there have been \<150 cases of glycogen-rich clear cell carcinoma of the breast reported worldwide. This group advocates for a more organized study of the immunophenotype of glycogen-rich clear cell carcinoma. This group reports three cases, and based upon their findings, they report that the immunophenotype of this rare subtype is not uniform between patients.

Primary clear cell tumors are rare and commonly misdiagnosed. A clear cell pattern occurs in the presence of glycogen, lipid or mucin \[[@RJU063C10]\]. The differential diagnoses for breast carcinoma possessing cells with relatively clear cytoplasm are lipid-rich carcinoma, hidradenocarcinoma, histiocytoid lobular carcinoma, apocrine carcinoma, clear cell 'sugar' carcinoma, glycogen-rich carcinoma, myoepithelial carcinoma, secretory carcinoma, adenomyoepithelioma, signet ring carcinoma, sebaceous carcinoma and metastatic renal cell carcinoma \[[@RJU063C3], [@RJU063C7], [@RJU063C10]\].

Clear cell carcinoma of the breast may be easily missed or misdiagnosed in a breast core biopsy specimen due to the fact that it tends to possess a papillary pattern with clear cell and pseudo-lactating changes, especially in young female patients. Special attention should be given to this specific subtype by pathologists and clinicians in order to potentially avoid misdiagnosis and delay of treatment, since it clearly follows an aggressive clinical course.
